|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
High performance range of insulated shipping systems |
 |
|
Laminar Medica’s Chilltherm® Global range of high performance insulated shipping systems, from 4 to 1130 litres product volume, are designed to offer optimal thermal protection for pharmaceutical products when exposed to extreme climates from -20°C to +40°C.
These shipping systems are pre-qualified to maintain payload integrity between +2°C and +8°C for transit durations of up to 120 hours. Real live data profiles have been used to give customers confidence that the quality and efficacy of their payloads will not be compromised during even the most demanding external temperatures. Cross hemisphere profile testing makes it ideal for clients making transcontinental shipments.
With only three sizes of cool packs used across the range and a common bill of materials for summer and winter pack outs the impact to warehousing and handling is minimised. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Intelsius Discusses In-Country Distribution At Iqpc Cool Chain Europe
Intelsius, a DGP company, a designer, manufacturer and distributor of
temperature-controlled packaging solutions, based in York, is directing
its focus on in-country distribution at the 14th Annual IQPC Cool Chain
Europe, held in Frankfurt, Germany, 26-29 January 2015.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 2nd Quarter 2014
Synergy Research Group
The Ministry of Health of Russian Federation approved 194 new clinical
trials of all types including local and bioequivalence studies during
the 2nd Quarter of 2014 (3% less than at the same period of the last
year).
The main contribution to the total number of studies was
made by multinational multi-center clinical trials (MMCT) and the number
of these studies stayed the same as in Q2 2013 – 81 studies. The number
of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to
59 in Q2 2014, a 22% decrease from last year’s figure. The number of
local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical
trials in Q2 2014.
More info >> |
|
 |
Industry Events |
 |
Central Labs
24-25 February 2015, Park Plaza Victoria, London
Packed
full of informative case studies and industry insight, the 12th Annual:
Central, Biomarker and Specialty Labs Summit will take place 24-25 Feb.
2015 in London.
More info >> |
|
|
